Cargando…

A novel expression system of domain I of human beta2 glycoprotein I in Escherichia coli

BACKGROUND: The antiphospholipid syndrome (APS), characterised by recurrent miscarriage and thrombosis, is a significant cause of morbidity and mortality. Domain I (DI) of human beta 2 glycoprotein I (β(2)GPI) is thought to contain crucial antibody binding epitopes for antiphospholipid antibodies (a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ioannou, Yiannis, Giles, Ian, Lambrianides, Anastasia, Richardson, Chris, Pearl, Laurence H, Latchman, David S, Isenberg, David A, Rahman, Anisur
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Methodology Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1402286/ https://www.ncbi.nlm.nih.gov/pubmed/16472380 http://dx.doi.org/10.1186/1472-6750-6-8

Ejemplares similares

Evaluating the conformation of recombinant domain I of β(2)-glycoprotein I and its interaction with human monoclonal antibodies
por: Pericleous, Charis, et al.
Publicado: (2011)

Development of a high yield expression and purification system for Domain I of Beta-2-glycoprotein I for the treatment of APS
por: McDonnell, Thomas, et al.
Publicado: (2015)

Antiphospholipid Antibodies to Domain I of Beta-2-Glycoprotein I Show Different Subclass Predominance in Comparison to Antibodies to Whole Beta-2-glycoprotein I
por: McDonnell, Thomas, et al.
Publicado: (2018)

Proof-of-concept study demonstrating the pathogenicity of affinity-purified IgG antibodies directed to domain I of β(2)-glycoprotein I in a mouse model of anti-phospholipid antibody-induced thrombosis
por: Pericleous, Charis, et al.
Publicado: (2015)

PEGylated Domain I of Beta-2-Glycoprotein I Inhibits the Binding, Coagulopathic, and Thrombogenic Properties of IgG From Patients With the Antiphospholipid Syndrome
por: McDonnell, Thomas C. R., et al.
Publicado: (2018)

Antibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with ‘seronegative’ antiphospholipid syndrome
por: Cousins, Laura, et al.
Publicado: (2015)

The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin
por: Giles, Ian, et al.
Publicado: (2005)

Interactions of human monoclonal and polyclonal antiphospholipid antibodies with serine proteases involved in hemostasis
por: Lambrianides, Anastasia, et al.
Publicado: (2011)

Oxidation of β2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome
por: Raimondo, Maria Gabriella, et al.
Publicado: (2017)

Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome
por: Pericleous, Charis, et al.
Publicado: (2016)

Serum nitrated nucleosome levels in patients with systemic lupus erythematosus: a retrospective longitudinal cohort study
por: Croca, Sara, et al.
Publicado: (2014)

Stable expression of a recombinant human antinucleosome antibody to investigate relationships between antibody sequence, binding properties, and pathogenicity
por: Mason, Lesley J, et al.
Publicado: (2005)

Anti-factor Xa antibodies in patients with antiphospholipid syndrome and their effects upon coagulation assays
por: Artim-Esen, Bahar, et al.
Publicado: (2015)

PEGylated Domain I of Beta-2-Glycoprotein I Inhibits Thrombosis in a Chronic Mouse Model of the Antiphospholipid Syndrome
por: Willis, Rohan, et al.
Publicado: (2022)

The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS
por: McDonnell, Thomas, et al.
Publicado: (2020)

Autoantibodies Directed Against Domain I of Beta2-Glycoprotein I
por: de Laat, Bas, et al.
Publicado: (2010)

Specific domain V reduction of beta-2-glycoprotein I induces protein flexibility and alters pathogenic antibody binding
por: Buchholz, Ina, et al.
Publicado: (2021)

IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study
por: Croca, Sara, et al.
Publicado: (2015)

Optimized expression of Plasmodium falciparum erythrocyte membrane protein 1 domains in Escherichia coli
por: Flick, Kirsten, et al.
Publicado: (2004)

Prediction of solubility on recombinant expression of Plasmodium falciparum erythrocyte membrane protein 1 domains in Escherichia coli
por: Ahuja, Sanjay, et al.
Publicado: (2006)

Novel Assays of Thrombogenic Pathogenicity in the Antiphospholipid Syndrome Based on the Detection of Molecular Oxidative Modification of the Major Autoantigen β(2)-Glycoprotein I
por: Ioannou, Yiannis, et al.
Publicado: (2011)

Production of glycoprotein vaccines in Escherichia coli
por: Ihssen, Julian, et al.
Publicado: (2010)

PEGylated drugs in rheumatology—why develop them and do they work?
por: McDonnell, Thomas, et al.
Publicado: (2014)

Development of high-yield autofluorescent protein microarrays using hybrid cell-free expression with combined Escherichia coli S30 and wheat germ extracts
por: Zárate, Xristo, et al.
Publicado: (2010)

Protocol: Precision engineering of plant gene loci by homologous recombination cloning in Escherichia coli
por: Roden, Laura C, et al.
Publicado: (2005)

The DNA relaxation activity and covalent complex accumulation of Mycobacterium tuberculosis topoisomerase I can be assayed in Escherichia coli: application for identification of potential FRET-dye labeling sites
por: Narula, Gagandeep, et al.
Publicado: (2010)

Factor Xa Mediates Calcium Flux in Endothelial Cells and is Potentiated by Igg From Patients With Lupus and/or Antiphospholipid Syndrome
por: Artim-Esen, Bahar, et al.
Publicado: (2017)

CRIMoClo plasmids for modular assembly and orthogonal chromosomal integration of synthetic circuits in Escherichia coli
por: Vecchione, Stefano, et al.
Publicado: (2019)

Gene doctoring: a method for recombineering in laboratory and pathogenic Escherichia coli strains
por: Lee, David J, et al.
Publicado: (2009)

Anticardiolipin and anti-beta2-glycoprotein I antibodies in Behcet's disease.
por: Kang, H. J., et al.
Publicado: (1998)

Posttranslational forms of beta 2-glycoprotein I in the pathogenesis of the antiphospholipid syndrome
por: El-Assaad, Fatima, et al.
Publicado: (2016)

The Significance of Anti-Beta-2-Glycoprotein I Antibodies in Antiphospholipid Syndrome
por: Brusch, Anna
Publicado: (2016)

Methodology of generation and purification of anti-beta 2 glycoprotein I antibodies
por: Alarcon, Marcelo, et al.
Publicado: (2019)

Improved detection of Escherichia coli and coliform bacteria by multiplex PCR
por: Molina, Felipe, et al.
Publicado: (2015)

Prediction of Escherichia coli expression performance in microtiter plates by analyzing only the temporal development of scattered light during culture
por: Ladner, Tobias, et al.
Publicado: (2017)

Hemagglutination by purified type I Escherichia coli pili
Publicado: (1977)

LOCALIZATION OF MACROMOLECULES IN ESCHERICHIA COLI : I. DNA and Proteins
por: Caro, Lucien G.
Publicado: (1961)

Improved production of class I lanthipeptides in Escherichia coli
por: Lee, Hyunji, et al.
Publicado: (2023)

Type I Error Control for Tree Classification
por: Jung, Sin-Ho, et al.
Publicado: (2014)

Variability in Exposure of Epitope G40-R43 of Domain I in Commercial Anti-Beta2-Glycoprotein I IgG ELISAs
por: Pelkmans, Leonie, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_kbnujds7tkmnsgv9mpsr88iav1